|
KIAA1804 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.78459999947245E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.13859999709243E-08 |
| Normal-vs-Stage2 |
1.766430E-04 |
| Normal-vs-Stage3 |
1.474320E-02 |
| Normal-vs-Stage4 |
5.698300E-02 |
| Stage1-vs-Stage2 |
8.397400E-01 |
| Stage1-vs-Stage3 |
2.091600E-01 |
| Stage1-vs-Stage4 |
2.550600E-01 |
| Stage2-vs-Stage3 |
2.187200E-01 |
| Stage2-vs-Stage4 |
2.601000E-01 |
| Stage3-vs-Stage4 |
9.716800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.78079999991444E-07 |
| Normal-vs-AfricanAmerican |
4.08600000000314E-05 |
| Normal-vs-Asian |
2.964100E-02 |
| Caucasian-vs-AfricanAmerican |
7.622400E-01 |
| Caucasian-vs-Asian |
8.116000E-01 |
| AfricanAmerican-vs-Asian |
7.088800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.44280001466302E-09 |
| Normal-vs-Female |
4.321200E-03 |
| Male-vs-Female |
9.638800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.952010E-04 |
| Normal-vs-Extreme_Weight |
5.41219999927733E-08 |
| Normal-vs-Obese |
4.219600E-04 |
| Normal-vs-Extreme_Obese |
1.462470E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.949410E-01 |
| Normal_Weight-vs-Obese |
6.065000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.004400E-01 |
| Extreme_Weight-vs-Obese |
4.311700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.658600E-01 |
| Obese-vs-Extreme_Obese |
8.511600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.520600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.229499999997E-05 |
| Normal-vs-Age(61-80Yrs) |
7.85199999464581E-08 |
| Normal-vs-Age(81-100Yrs) |
9.11380000023776E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.037040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.090280E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.562500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.789900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.155500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.731400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.06140000000199E-06 |
| Normal-VS-Type2 PRCC |
3.12860000017956E-07 |
| Normal-VS-KIRP CIMP |
8.147600E-01 |
| Normal-VS-Unclassified PRCC |
9.370700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.671580E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.258750E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.688800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.168000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.764200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.853700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.66090000045472E-07 |
| Normal-vs-N1 |
3.078200E-01 |
| Normal-vs-N2 |
8.354500E-02 |
| N0-vs-N1 |
1.291990E-02 |
| N0-vs-N2 |
5.970200E-01 |
| N1-vs-N2 |
4.031600E-01 |
|
|
